The performance of companies tied to Sildenafil's legacy presents a intricate investment landscape. While the initial boom generated substantial returns , generic copies have significantly eroded revenue. https://fatallisto.com/story11745309/copyright-s-flagship-product-and-big-pharma-a-risky-venture